Sign in
UC

Ultra Clean Holdings, Inc. (UCTT)·Q4 2024 Earnings Summary

Executive Summary

  • Q4 revenue was $563.3M with non-GAAP EPS of $0.51; gross/operating margins compressed sequentially on product mix and region, but results landed within prior Q4 guidance (rev $535–$585M; non-GAAP EPS $0.34–$0.54) .
  • AI-related demand (advanced packaging, CMP) supported Products growth to $503.5M, while Services softened to $59.8M; management cited China-for-China inventory digestion and extended qualifications driving near-term “air pockets” .
  • Q1’25 outlook: revenue $505–$555M; GAAP EPS $(0.11)–$0.09; non-GAAP EPS $0.22–$0.42. Management expects a flattish 1H25 with potential recovery in 2H25; 2025 tax rate targeted in the low- to mid-20s .
  • Potential stock catalysts: balance sheet “alternatives” review; long-term AI exposure and stated capacity to support ~$4B revenue run-rate; China export controls not impacting shipments due to local manufacturing footprint .

What Went Well and What Went Wrong

  • What Went Well

    • AI-driven demand continued to expand beyond packaging into CMP, helping Products revenue grow Q/Q to $503.5M; “customers are investing in CMP to take their yield up, especially in the AI area” .
    • Non-GAAP EPS rose to $0.51 (vs $0.35 in Q3) on lower tax rate and lower OpEx ratio despite modest gross margin compression; OpEx fell to 9.8% of revenue from 10.5% in Q3 .
    • Strategic footprint and flexibility underpin long-term positioning; “global manufacturing capacity to support a $4 billion revenue run rate” and outperformance of WFE in 2024 (+21% y/y revenue) highlight share gains .
  • What Went Wrong

    • Gross margin compressed sequentially (non-GAAP 16.8% vs 17.8% in Q3) on product/geo mix and year-end inventory true-ups; product GM weakened as high-margin China mix fell .
    • China-for-China slowed (Q4 direct China ~ $40M vs $55M in Q3) due to longer qualifications and inventory digestion; management expects softness to persist through 1H25 .
    • Near-term visibility limited; management guided a flattish 1H25, with recovery skewed to 2H25 and WFE growth of ~5% in 2025, targeting 5–10% outperformance but acknowledging mix risk .

Financial Results

MetricQ2 2024Q3 2024Q4 2024
Total Revenue ($M)516.1 540.4 563.3
Products Revenue ($M)452.7 479.0 503.5
Services Revenue ($M)63.4 61.4 59.8
GAAP Gross Margin %17.1% 17.3% 16.3%
Non-GAAP Gross Margin %17.7% 17.8% 16.8%
GAAP Operating Margin %4.4% 4.7% 4.6%
Non-GAAP Operating Margin %6.9% 7.3% 7.0%
GAAP Diluted EPS ($)0.42 (0.05) 0.36
Non-GAAP EPS ($)0.32 0.35 0.51

Segment margin mix (Non-GAAP)

Segment GM %Q2 2024Q3 2024Q4 2024
Products GM %15.6% 16.1% 15.2%
Services GM %32.7% 30.5% 29.8%

Q4 YoY snapshot

MetricQ4 2023Q4 2024
Total Revenue ($M)444.8 563.3
Products Revenue ($M)389.7 503.5
Services Revenue ($M)55.1 59.8
GAAP Diluted EPS ($)(0.08) 0.36
Non-GAAP EPS ($)0.19 0.51
GAAP Gross Margin %16.0% 16.3%
Non-GAAP Gross Margin %16.7% 16.8%

KPIs and balance sheet

KPIQ2 2024Q3 2024Q4 2024
Cash & Equivalents ($M)319.5 318.2 313.9
Cash from Operations ($M)23.2 14.9 17.1
Non-GAAP Tax Rate %24.7% 27.1% 14.5%
China Direct Revenue ($M)~55 ~40
China Direct Revenue FY2024 ($M)~215

Non-GAAP adjustments (Q4): amortization of intangibles $7.5M, SBC $4.7M, legal costs $1.1M; fair value adjustment of $(7.1)M; tax effects/valuation allowance net impact per reconciliation .

Guidance Changes

MetricPeriodPrevious GuidanceCurrent Guidance/OutcomeChange
Revenue ($M)Q4 2024$535–$585 Actual: $563.3 In range
Non-GAAP EPS ($)Q4 2024$0.34–$0.54 Actual: $0.51 Near high end
Revenue ($M)Q1 2025$505–$555 New
GAAP EPS ($)Q1 2025$(0.11)–$0.09 New
Non-GAAP EPS ($)Q1 2025$0.22–$0.42 New
Tax Rate (Non-GAAP)FY 2025Low–mid 20s% New

Notes: Company does not guide margins or OpEx, but emphasized expense discipline and a comprehensive review of cost structure and balance sheet alternatives .

Earnings Call Themes & Trends

TopicPrevious Mentions (Q2 2024)Previous Mentions (Q3 2024)Current Period (Q4 2024)Trend
AI/Tech initiatives (HBM, packaging, CMP)Strength in HBM and advanced packaging supporting AI apps Broadened to CMP for large AI chips; strong plating from Czech site Continued AI/CMP contribution, offsets China softness Positive, broadening
Regional: China-for-China$40–$50M/quarter run-rate emerging ~$55M in Q3; expected to remain elevated into 2025 ~$40M in Q4; softness from longer quals/inventory digestion likely through 1H25 Near-term soft
Supply chain/inventoryCycle times short; inventory in pipeline FX headwinds; operating efficiency improving Year-end inventory true-ups; product GM impact Mixed near term
Export controls/regulatoryExport controls not impacting shipments due to local China manufacturing/engineering Neutral/managed
WFE/macro outlookMid-teens WFE growth in 2025 anticipated; UCT to outperform 10–14% WFE for 2025; UCT to grow faster ~5% WFE growth in 2025; aiming to outperform by 5–10% Tempered for 2025
Footprint/capacityMalaysia ramp doubled since Q4; site optimization Malaysia/litho share gains discussed “Capacity to support a $4B run-rate” Positioned for upturn

Management Commentary

  • “UCT's fourth quarter capped off a strong year with total revenue growing 21 percent over the prior year, significantly outperforming the overall WFE market.” – CEO .
  • “We now have the global manufacturing capacity to support a $4 billion revenue run rate.” – CFO .
  • “We are experiencing some unexpected demand softness from our in China for China business relating to extended qualification timelines and some inventory digestion.” – CFO .
  • On AI/CMP: “Customers are investing in CMP to take their yield up, especially in the AI area.” – Management .
  • On export controls: “They did not impact our shipments…our shipments within China are encapsulated within China with manufacturing and engineering happening in China.” – Management .

Q&A Highlights

  • China exposure: ~$40M in Q4; ~$215M FY24; softness from a customer ramp issue (expected resolved by Q2), broader demand softening, and inventory burn; ex-China business “flattish” into Q1 .
  • Export restrictions: No current impact due to local China manufacturing/engineering; shipments remain compliant .
  • Margin drivers: Q4 product GM weakness tied to lower China mix and year-end inventory adjustments; expect gross margin “somewhat flat” into Q1 while focusing on cost structure .
  • Outlook/tone: 1H25 flattish; potential 2H25 recovery; WFE +~5% in 2025 with targeted 5–10% outperformance; evaluating balance sheet alternatives to enhance flexibility and EPS .

Estimates Context

  • S&P Global consensus (revenue/EPS) for Q4 2024 was unavailable due to data access limits at the time of analysis; as a proxy, UCT had guided Q4 revenue of $535–$585M and non-GAAP EPS of $0.34–$0.54 and reported $563.3M and $0.51, respectively, landing within ranges .
  • If you want, I can refresh and add Wall Street consensus and the explicit beat/miss deltas once S&P Global access is restored (typical source of record for PM workflows).

Key Takeaways for Investors

  • Near-term: Q1’25 guide implies sequential downtick vs Q4 amid China softness; margins likely flat near term; tactically skew exposure to AI-driven products that maintained resilience in Q4 .
  • Execution: Non-GAAP EPS improvement to $0.51 and OpEx ratio down to 9.8% demonstrate operating discipline into a softer mix environment .
  • Structural positioning: Broadening AI exposure (packaging, CMP) and diversified footprint (Czech, Malaysia, China) support long-term share gains; management asserts capacity to sustain a ~$4B run-rate .
  • China risk managed, but softer 1H25: Localized operations mitigate export risks, but inventory/qualification dynamics weigh on 1H; watch for 2H reacceleration inflection .
  • 2025 framework: Internal view of ~5% WFE growth with a plan to outperform by 5–10% suggests relative outperformance potential if mix normalizes and China stabilizes .
  • Optionality: Balance sheet “alternatives” under consideration could reduce interest expense and/or support M&A, aiding EPS power into the next upcycle .
  • Update needed: Add explicit Street consensus and beat/miss once S&P Global access resumes for tighter trading setups.